103 related articles for article (PubMed ID: 30392196)
1. Raman spectroscopy with a 1064-nm wavelength laser as a potential molecular tool for prostate cancer diagnosis: a pilot study.
Magalhães FL; Machado AMC; Paulino E; Sahoo SK; de Paula AM; Garcia AM; Barman I; Soares JS; Mamede M
J Biomed Opt; 2018 Nov; 23(12):1-6. PubMed ID: 30392196
[TBL] [Abstract][Full Text] [Related]
2. Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.
Aubertin K; Trinh VQ; Jermyn M; Baksic P; Grosset AA; Desroches J; St-Arnaud K; Birlea M; Vladoiu MC; Latour M; Albadine R; Saad F; Leblond F; Trudel D
BJU Int; 2018 Aug; 122(2):326-336. PubMed ID: 29542855
[TBL] [Abstract][Full Text] [Related]
3. Using the Method of "Optical Biopsy" of Prostatic Tissue to Diagnose Prostate Cancer.
Artemyev DN; Kukushkin VI; Avraamova ST; Aleksandrov NS; Kirillov YA
Molecules; 2021 Mar; 26(7):. PubMed ID: 33807257
[TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced Raman spectroscopy + support vector machine: a new noninvasive method for prostate cancer screening?
Li S; Guo Z; Liu Z
Expert Rev Anticancer Ther; 2015 Jan; 15(1):5-7. PubMed ID: 25525666
[TBL] [Abstract][Full Text] [Related]
5. MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.
Iordanescu G; Brendler C; Crawford SE; Wyrwicz AM; Venkatasubramanian PN; Doll JA
J Magn Reson Imaging; 2015 Sep; 42(3):651-7. PubMed ID: 25522916
[TBL] [Abstract][Full Text] [Related]
6. Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Shi HB; Zhang YD
J Magn Reson Imaging; 2018 Aug; 48(2):499-506. PubMed ID: 29437268
[TBL] [Abstract][Full Text] [Related]
7. Use of picosecond Kerr-gated Raman spectroscopy to suppress signals from both surface and deep layers in bladder and prostate tissue.
Prieto MC; Matousek P; Towrie M; Parker AW; Wright M; Ritchie AW; Stone N
J Biomed Opt; 2005; 10(4):44006. PubMed ID: 16178640
[TBL] [Abstract][Full Text] [Related]
8. Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
Giunchi F; Brunocilla E; Borghesi M; Rizzi S; Ricci MS; Romagnoli D; Martorana G; Schiavina R; Fiorentino M
Clin Genitourin Cancer; 2014 Oct; 12(5):325-9. PubMed ID: 24583160
[TBL] [Abstract][Full Text] [Related]
9. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
10. [Progress in study of biomolecular damages by Raman spectroscopy].
Li LL; Zhao LJ; Zhong RG
Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Sep; 32(9):2422-6. PubMed ID: 23240410
[TBL] [Abstract][Full Text] [Related]
11. [Study on bladder cancer tissues with Raman spectroscopy].
Wang L; Fan JH; Guan ZF; Liu Y; Zeng J; He DL; Huang LQ; Wang XY; Gong HL
Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Jan; 32(1):123-6. PubMed ID: 22497142
[TBL] [Abstract][Full Text] [Related]
12. Automated analysis of urinary stone composition using Raman spectroscopy: pilot study for the development of a compact portable system for immediate postoperative ex vivo application.
Miernik A; Eilers Y; Bolwien C; Lambrecht A; Hauschke D; Rebentisch G; Lossin PS; Hesse A; Rassweiler JJ; Wetterauer U; Schoenthaler M
J Urol; 2013 Nov; 190(5):1895-900. PubMed ID: 23770149
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
14. Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.
Citak-Er F; Vural M; Acar O; Esen T; Onay A; Ozturk-Isik E
Biomed Res Int; 2014; 2014():690787. PubMed ID: 25544944
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.
Hsieh TF; Chang CH; Chen WC; Chou CL; Chen CC; Wu HC
J Chin Med Assoc; 2005 Apr; 68(4):167-71. PubMed ID: 15850066
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of prostate carcinoma from benign prostate tissue fragments in vitro by estimating the gross biochemical alterations through Raman spectroscopy.
Silveira L; Leite KR; Silveira FL; Srougi M; Pacheco MT; Zângaro RA; Pasqualucci CA
Lasers Med Sci; 2014 Jul; 29(4):1469-77. PubMed ID: 24619139
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
[TBL] [Abstract][Full Text] [Related]
18. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
[TBL] [Abstract][Full Text] [Related]
20. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?
Tollefson M; Magera J; Sebo T; Cohen J; Drauch A; Maier J; Frank I
BJU Int; 2010 Aug; 106(4):484-8. PubMed ID: 20201840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
